Episode Details

Back to Episodes
JAMA Neurology : Fremanezumab for the Treatment of Migraine and Major Depressive Disorder

JAMA Neurology : Fremanezumab for the Treatment of Migraine and Major Depressive Disorder

Published 1 year, 4 months ago
Description

Interview with Richard B. Lipton, MD, author of Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder. Hosted by Cynthia E. Armand, MD.

Related Content:

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us